Blaise A Coleman
Chief Executive Officer bij ENDO INTERNATIONAL PLC
Vermogen: 169 $ op 31-03-2024
Profiel
Blaise A Coleman is currently the President, Chief Executive Officer & Director at Endo International Plc.
Previously, he held positions as the Chairman, President & Chief Executive Officer at BioSpecifics Technologies Corp.
and as the Senior Director-Commercial Finance at AstraZeneca US Investments Ltd.
He also served as the Chief Financial Officer at AstraZeneca AB from 2013 to 2015.
Mr. Coleman completed his undergraduate degree at Widener University and earned an MBA from The Fuqua School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ENDO INTERNATIONAL PLC
0.18% | 12-04-2023 | 422 066 ( 0.18% ) | 169 $ | 31-03-2024 |
Actieve functies van Blaise A Coleman
| Bedrijven | Functie | Begin |
|---|---|---|
| ENDO INTERNATIONAL PLC | Chief Executive Officer | 06-03-2020 |
Eerdere bekende functies van Blaise A Coleman
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Director of Finance/CFO | 01-01-2015 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Chief Executive Officer | - |
AstraZeneca US Investments Ltd.
 AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK and was founded in 2002. | Corporate Officer/Principal | - |
Opleiding van Blaise A Coleman
| Widener University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENDO INTERNATIONAL PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
AstraZeneca US Investments Ltd.
AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK and was founded in 2002. | Finance |
